课题基金 / 基金详情

项目摘要

项目成果

VLADIMIR GEVORGYAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The development of novel expeditious and efficient methodologies toward the synthesis of biologically significant heterocyclic compounds is planned. The proposed project consists of four major sections. The first section is devoted to the investigation and development of novel cycloisomerization approaches toward monocyclic and fused furans, pyrroles, and thiophenes, and to the development of cascade migration/cyclization methodologies en route to highly substituted heterocycles. The second section is directed toward investigation of the scope of the recently discovered transannulation reaction as a highly attractive modular approach to a variety of diverse heteroaromatic scaffolds. The third section covers transition metal- and Lewis acid-catalyzed C-H functionalization of aromatic and heterocyclic building blocks employing a recently proposed Si-tether motif. The fourth section is aimed at development of new synthetic approaches for the rapid construction of naturally occurring and unnatural heterocyclic molecules of biological importance using methodologies developed in our laboratories. Synthetic targets for the proposed research include various diversely substituted indolizines not easily available by existing techniques, potential selective group V sPLA2 inhibitors; lamellarin D and its analogs; novel lamellarin-campthothecin hybrid pentacyclic scaffolds, potential topoisomerase I inhibitors, and tetra- and pentacyclic heterocyclic skeletons, potential QR2 and aromatase inhibitors. The synthetic part of the proposed work toward selected targets is essential as it may lead to discovery of potent anti-inflammatory and anticancer agents. The methodological part of this proposal toward general and efficient methods for construction and functionalization of diverse fused heterocycles has even broader impact, as upon development, it would dramatically broaden the arsenal of libraries of biologically important molecules available for medicinal chemists and biologists, and will most certainly impact drug discovery research and related health-oriented sciences.
期刊论文(70)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1021/ol400148r
发表时间: 2013-02-15
期刊: ORGANIC LETTERS
影响因子: 5.2
作者: [Gulevich, Anton V., Helan, Victoria, Wink, Donald J., Gevorgyan, Vladimir]
通讯作者: Gevorgyan, Vladimir
DOI: 10.1021/ja1033167
发表时间: 2010-06-23
期刊: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
影响因子: 15
作者: [Chernyak, Natalia, Dudnik, Alexander S., Huang, Chunhui, Gevorgyan, Vladimir]
通讯作者: Gevorgyan, Vladimir
DOI: 10.1021/ol400977r
发表时间: 2013-05-17
期刊: ORGANIC LETTERS
影响因子: 5.2
作者: [Kuznetsov, Alexey, Onishi, Yoshiharu, Inamoto, Yoshihiro, Gevorgyan, Vladimir]
通讯作者: Gevorgyan, Vladimir
DOI: 10.1016/j.tetlet.2015.01.006
发表时间: 2015-06-03
期刊: Tetrahedron letters
影响因子: 1.8
作者: [Shiroodi RK, Vera CI, Dudnik AS, Gevorgyan V]
通讯作者: Gevorgyan V
55
    Transition Metal-Radical Hybrid Methods for Organic Synthesis
    • 批准号:
      9311318
    • 项目类别:
    • 资助金额:
      $29.31万
    • 财政年份:
      2017
    • 负责人:
      VLADIMIR GEVORGYAN
    • 依托单位:
    Transition Metal-Radical Hybrid Methods for Organic Synthesis
    • 批准号:
      10624462
    • 项目类别:
    • 资助金额:
      $31.98万
    • 财政年份:
      2017
    • 负责人:
      VLADIMIR GEVORGYAN
    • 依托单位:
    Transition Metal-Radical Hybrid Methods for Organic Synthesis
    • 批准号:
      10470374
    • 项目类别:
    • 资助金额:
      $31.98万
    • 财政年份:
      2017
    • 负责人:
      VLADIMIR GEVORGYAN
    • 依托单位:
    Transition Metal-Radical Hybrid Methods for Organic Synthesis
    • 批准号:
      9900019
    • 项目类别:
    • 资助金额:
      $29.53万
    • 财政年份:
      2017
    • 负责人:
      VLADIMIR GEVORGYAN
    • 依托单位:
    国内基金
    海外基金
    具有抗癌活性的天然产物金霉酸(Aureolic acids)全合成与选择性构建2-脱氧糖苷键
    • 批准号:
      22007039
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2020
    • 负责人:
      王黎明
    • 依托单位:
    海洋放线菌来源聚酮类化合物Pteridic acids生物合成机制研究
    手性Lewis Acids催化的分子内串联1,5-氢迁移/环合反应及其在构建结构多样性手性含氮杂环化合物中的应用
    对空气稳定的新型的有机金属Lewis Acids催化剂制备、表征与应用研究
    • 批准号:
      21172061
    • 项目类别:
      面上项目
    • 资助金额:
      30.0万元
    • 批准年份:
      2011
    • 负责人:
      许新华
    • 依托单位: